Led spin-out, formation and development of Exa Health from Gauss Surgical (acquired by Stryker). Exa Health uses AI to drive at-home diagnostic testing.

Strategy lead for Gauss as well as responsible for driving company's global expansion, with focus on market entry in Asia-Pacific

Senior management team member responsible for Operations, Marketing and Customer Success for company's AI-based blood loss monitoring solution for in-patient surgical procedures in the US. Developed initial beachhead market for Gauss Surgical's technology by aligning product positioning, product configuration, messaging and sales process to drive account acquisition.

Led Veracyte's Endocrinology Marketing Team for company's flagship genomic diagnostic product, Afirma. Responsible for all brand and product marketing activities, including brand strategy, product development and marketing communications.

Member of senior management team with formal leadership responsibility for Communications, Medical Affairs, Commercial Marketing and Clinical Education. Led development of integrated product and company messaging by creating dynamic sales tools and product positioning content across a broad media spectrum. Developed commercialization strategies and executed product launches, sales process development, and sales and user training.

Involved in all aspects of growing Marketing group at Avinger - from initial commercial product into multiple platforms and generations of products. Led marketing product development and commercialization activities for all products spanning hardware, software and disposable technologies.

Responsible for all activities related to MicroEnsure's expansion into new geographic markets to enable delivery of microinsurance products to low-income and poor in the developing world, including creating new MicroEnsure country operations in Indonesia, Tanzania and Kenya. Conducted initial market assessments, built strategic partnerships with insurance underwriters and distribution channels, established country operations, hired/coached local management teams and lobbied national governments.

Awarded one-year, full-time role as a Beacon Capital Fellow from the Kellogg School of Management to expand microfinance products and operations through Opportunity International's network of lending institutions in the developing world. Supported CEO and senior management in strategic initiatives across the organization including developing a global operations plan, assessing new market expansion into the DR Congo, and reviewing subsidiary country performance and portfolio contribution. Co-authored white paper: "Banking Rollout Approaches to Rural Markets."

Member of Finance team working across FP&A, Commercial Finance, Accounting and Treasury services. Performed competitive market assessments, conducted benchmarking analyses, and developed model to track inventory levels for developing-world drug access program.

Co-managed $3.5 billion in proprietary trading positions and institutional credit exposure for over 75 healthcare companies as part of Wachovia's Credit Capital Markets group. Followed general market activities and specific company credits including developing investment opinions (buy/sell recommendations) and identifying investment/trading opportunities across a range of securities (swaps, converts, bonds, loans).

Member of Bank of America's Strategic Alliances & Investments group (Principal Investing) focused on evaluating and executing investments in strategic partners and joint-venture opportunities. Responsible for due diligence, deal structuring, negotiation and post-deal oversight of portfolio companies. Prepared quarterly investment reviews and tracked regulatory reporting requirements.

Member of Mergers & Strategic Advisory Group (Investment Banking Division). Evaluated, developed and advised on M&A, takeover defense, corporate structuring and financing strategies for both public and private clients. Developed comprehensive valuation models including discounted cash flow, merger, leveraged buyout, comparable company and comparable transaction analyses.